MA39111A1 - Dispositif oculaire - Google Patents

Dispositif oculaire

Info

Publication number
MA39111A1
MA39111A1 MA39111A MA39111A MA39111A1 MA 39111 A1 MA39111 A1 MA 39111A1 MA 39111 A MA39111 A MA 39111A MA 39111 A MA39111 A MA 39111A MA 39111 A1 MA39111 A1 MA 39111A1
Authority
MA
Morocco
Prior art keywords
eye
delivery device
drug delivery
polymer
intraocular drug
Prior art date
Application number
MA39111A
Other languages
English (en)
Inventor
Jean-Marie Rakic
Jean-Michel Foidart
Original Assignee
Eyed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyed Pharma filed Critical Eyed Pharma
Publication of MA39111A1 publication Critical patent/MA39111A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • A61F2240/005—Templates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un dispositif d'administration de médicaments intraoculaire à libération prolongée comprenant : (a) un cœur de matrice polymère dans lequel au moins un agent thérapeutique est mélangé, et ; (b) un enduit polymère entourant complètement ledit matériau de matrice polymère ; ledit cœur de matrice polymère et l'enduit polymère étant insolubles et inertes dans les fluides oculaires, et le dispositif d'administration de médicaments intraoculaire à libération prolongée ayant la forme d'un segment annulaire souple et devant être inséré dans le sulcus de l'œil intact et/ou de l'oeil pseudophaque.
MA39111A 2013-11-14 2014-11-14 Dispositif oculaire MA39111A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13192889 2013-11-14
PCT/EP2014/074644 WO2015071427A1 (fr) 2013-11-14 2014-11-14 Dispositif oculaire

Publications (1)

Publication Number Publication Date
MA39111A1 true MA39111A1 (fr) 2017-04-28

Family

ID=49584627

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39111A MA39111A1 (fr) 2013-11-14 2014-11-14 Dispositif oculaire

Country Status (17)

Country Link
US (1) US9999595B2 (fr)
EP (2) EP3068372B1 (fr)
JP (1) JP6602761B2 (fr)
KR (1) KR20160085870A (fr)
CN (1) CN105792812B (fr)
AU (1) AU2014350095B9 (fr)
BR (1) BR112016010638B1 (fr)
CA (1) CA2929684C (fr)
CL (1) CL2016001160A1 (fr)
EA (1) EA032183B1 (fr)
ES (2) ES2740352T3 (fr)
HK (1) HK1223271A1 (fr)
IL (1) IL245405A0 (fr)
MA (1) MA39111A1 (fr)
MX (1) MX2016006142A (fr)
TN (1) TN2016000162A1 (fr)
WO (1) WO2015071427A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10507101B2 (en) 2014-10-13 2019-12-17 W. L. Gore & Associates, Inc. Valved conduit
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US11406533B2 (en) 2017-03-17 2022-08-09 W. L. Gore & Associates, Inc. Integrated aqueous shunt for glaucoma treatment
KR20210013089A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
KR20210013088A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP3803866A4 (fr) 2018-05-24 2022-03-16 Nureva Inc. Procédé, appareil et supports lisibles par ordinateur pour gérer des sources sonores semi-constantes (persistantes) dans des zones de capture/foyer de microphones
US11298262B2 (en) 2018-07-23 2022-04-12 The Regents Of The University Of Colorado, A Body Corporate Ophthalmic device for drug delivery
CA3110653A1 (fr) 2018-08-29 2020-03-05 W. L. Gore & Associates, Inc. Systemes et procedes d'administration de therapie par medicaments
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
KR20250051157A (ko) 2019-06-05 2025-04-16 리제너론 파아마슈티컬스, 인크. 정밀 투여량 전달을 위한 디바이스 및 방법
GB2601922B (en) 2019-06-27 2024-04-24 Layerbio Inc Ocular device drub delivery systems
US11399977B2 (en) 2020-06-04 2022-08-02 SpyGlass Pharma, Inc. Ophthalmic implant system for drug delivery
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
US12527691B2 (en) 2021-11-05 2026-01-20 W. L. Gore & Associates, Inc. Fluid drainage devices, systems, and methods
EP4433035A1 (fr) * 2021-11-17 2024-09-25 Celanese EVA Performance Polymers LLC Dispositif implantable pour le traitement d'une maladie oculaire inflammatoire
CN114224822B (zh) * 2022-01-28 2023-07-14 复旦大学附属眼耳鼻喉科医院 一种眼部缓释给药植入物及其制造方法
EP4233836B1 (fr) 2022-02-24 2024-11-06 Eyed Pharma Dispositif d'administration intraoculaire de medicament comprenant un oeillet
US12193972B2 (en) 2022-07-22 2025-01-14 SpyGlass Pharma, Inc. Intraocular drug delivery systems and methods of use
WO2024020505A2 (fr) * 2022-07-22 2024-01-25 SpyGlass Pharma, Inc. Systèmes d'administration de médicament intraoculaire et méthodes d'utilisation
CN121038751A (zh) * 2023-06-27 2025-11-28 博爱视觉有限责任公司 一种眼球植入体
KR102783540B1 (ko) * 2023-12-22 2025-03-17 조선대학교산학협력단 인공수정체 및 이의 제조방법
WO2026022371A1 (fr) 2024-07-26 2026-01-29 Eyed Pharma Sa Dispositif de retenue pour dispositif d'administration intraoculaire de médicaments
WO2026022370A1 (fr) 2024-07-26 2026-01-29 Eyed Pharma Sa Injecteur pour dispositif d'administration de médicament intraoculaire

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4668506A (en) 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4718905A (en) * 1986-08-13 1988-01-12 Freeman Jerre M Haptic element using ion beam implantation for an intraocular lens
US4997652A (en) 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5928282A (en) * 1997-06-13 1999-07-27 Bausch & Lomb Surgical, Inc. Intraocular lens
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
FR2787991B1 (fr) * 1998-12-31 2001-05-25 Medicale De Prec S M P Sa Soc Dispositif pour traiter la presbytie ou autre affection oculaire
US7090888B2 (en) * 2002-01-18 2006-08-15 Snyder Michael E Sustained release ophthalmological device and method of making and using the same
FR2844703B1 (fr) 2002-09-25 2005-07-08 Alain Nicolas Gilg Dispositif intraoculaire pour restaurer l'accommodation de l'oeil atteint de presbytie
US20090018650A1 (en) 2003-06-19 2009-01-15 Boxer Wachler Brian S Ophthalmological zonular stretch segment for treating presbyopia
CA2601864A1 (fr) * 2005-04-08 2006-10-19 Surmodics, Inc. Implants a liberation prolongee et methodes d'administration sous-retinienne d'agents bioactifs pour traiter ou prevenir les maladies de la retine
WO2009140246A2 (fr) * 2008-05-12 2009-11-19 University Of Utah Research Foundation Dispositif d'administration intraoculaire de médicament et procédés associés
KR20110056516A (ko) * 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 점막 또는 피부를 통한 치료제의 흡수 개선
US20100226962A1 (en) 2009-03-03 2010-09-09 Rodstrom Theron R Peri-corneal drug delivery device
EP2555749B1 (fr) * 2010-04-06 2016-10-26 Allergan, Inc. Implants réservoirs à libération prolongée pour administration de médicament intracamérulaire

Also Published As

Publication number Publication date
US20160287513A1 (en) 2016-10-06
EP3068372B1 (fr) 2019-05-08
AU2014350095A1 (en) 2016-06-09
BR112016010638B1 (pt) 2023-01-31
TN2016000162A1 (en) 2017-10-06
MX2016006142A (es) 2016-12-09
ES2864274T3 (es) 2021-10-13
KR20160085870A (ko) 2016-07-18
ES2740352T3 (es) 2020-02-05
US9999595B2 (en) 2018-06-19
CA2929684C (fr) 2022-02-22
EP3068372A1 (fr) 2016-09-21
CL2016001160A1 (es) 2017-03-17
CN105792812B (zh) 2020-10-23
AU2014350095B2 (en) 2019-08-29
EA201690967A1 (ru) 2016-10-31
EP3566693B1 (fr) 2021-02-17
EA032183B1 (ru) 2019-04-30
CA2929684A1 (fr) 2015-05-21
JP6602761B2 (ja) 2019-11-06
EP3566693A1 (fr) 2019-11-13
IL245405A0 (en) 2016-06-30
JP2016537370A (ja) 2016-12-01
AU2014350095B9 (en) 2019-09-12
BR112016010638A2 (fr) 2017-08-08
CN105792812A (zh) 2016-07-20
HK1223271A1 (zh) 2017-07-28
WO2015071427A1 (fr) 2015-05-21

Similar Documents

Publication Publication Date Title
MA39111A1 (fr) Dispositif oculaire
USD839294S1 (en) Display screen with graphical user interface for closed-loop medication delivery
EP3999143A4 (fr) Dispositif de pancréas artificiel en boucle fermée, doté d'une détection et d'une perfusion intégrées
EP3518763A4 (fr) Personnalisation de tailles de repas prédéfinis dans un système d'administration d'insuline
MA49677A (fr) Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
EP4173615A3 (fr) Dispositifs d'administration de médicaments intravésicaux et procédés comprenant des systèmes de matrice médicament-polymère élastique
MA50553A (fr) Dispositif d'administration de médicament avec détection de positionnement et de débit
EP3478301A4 (fr) Modification de parasites pour l'administration de protéines dans le système nerveux central.
EP3694583A4 (fr) Systèmes intelligents d'administration de médicament et procédés de recommandation et de gestion de dose
WO2014179568A3 (fr) Implant oculaire à deux couches
MA51131A (fr) Dispositif d'administration de médicament doté d'un système de détection de seringue
WO2010068281A3 (fr) Dispositif d’administration de médicament par lentille de contact
AR053304A1 (es) Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
EP3969099A4 (fr) Réseaux de microaiguilles ayant des caractéristiques de contre-dépouille pour l'administration cutanée et non cutanée de médicaments
EP3442481A4 (fr) Systèmes et procédés d'administration de médicaments à un oeil
RU2016148324A (ru) Предварительно заполненный пластиковый шприц, содержащий антагонист vegf
WO2012129407A3 (fr) Systèmes de chargement de lentille intra-oculaire et procédés d'utilisation
EP3903856A4 (fr) Dispositif d'administration de médicament et système d'administration de médicament
MA50566A (fr) Dispositifs d'administration de médicament et procédés destinés à être utilisés avec un cathéter urinaire
EP2554199A4 (fr) Dispositif d'administration de médicament et dispositif d'injection de médicament
EP4049653A4 (fr) Microgel intraoculaire injectable servant de système d'administration de médicament, et hydrogel le comprenant
MA55077A (fr) Dispositif d'administration de médicament avec système de détection
EP3600504C0 (fr) Dispositif d'administration de médicaments en poudre sèche
WO2008141111A3 (fr) Polymères conjugués avec des médicaments à base de platine
MA55518A (fr) Dispositif d'administration de médicament avec système de dosage à engrenages